Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-09

Clinical Trial Update: Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on measuring serum levels of two antiepileptic drugs during conversion in patients with epilepsy, sponsored by GlaxoS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 4 | Status: COMPLETED